Brevan Howard Capital Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13M Sell
45,270
-1,178
-3% -$117K 0.04% 328
2026
Q1
$4.37M Buy
46,448
+41,932
+929% +$4.18M 0.04% 281
2025
Q4
$446K Buy
4,516
+980
+28% +$94.8K ﹤0.01% 1173
2025
Q3
$300K Buy
+3,536
New +$279K ﹤0.01% 1567
2025
Q2
– Sell
-15,422
Closed -$934K – 1920
2025
Q1
$934K Sell
15,422
-37,531
-71% -$2.62M 0.01% 526
2024
Q4
$3.66M Buy
52,953
+16,164
+44% +$1.15M 0.02% 183
2024
Q3
$2.43M Buy
36,789
+14,066
+62% +$897K 0.02% 237
2024
Q2
$1.38M Buy
22,723
+9,091
+67% +$515K 0.01% 288
2024
Q1
$777K Buy
13,632
+7,265
+114% +$436K 0.01% 338
2023
Q4
$400K Buy
+6,367
New +$360K ﹤0.01% 585

Other funds holding INCY

Brevan Howard Capital Management's INCY Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Incyte (INCY) stake by 2.5% in Q2 2026, selling an estimated $117K and leaving 45,270 shares worth $5.13M. The position accounts for 0.04% of the portfolio, ranked #328.

Brevan Howard Capital Management first reported a position in INCY in Q4 2023 and has held it in 10 quarters since. 861 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Brevan Howard Capital Management held 45,270 shares of Incyte worth $5.13M as of Q2 2026.
  • Brevan Howard Capital Management sold 1,178 Incyte shares in Q2 2026, an estimated $117K.
  • Incyte made up 0.04% of Brevan Howard Capital Management's portfolio in Q2 2026, its #328 holding.
  • Brevan Howard Capital Management first reported a position in Incyte in Q4 2023 and has held it in 10 quarters since.
  • 861 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.